Literature DB >> 8933546

Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska.

X T Ussery1, B D Gessner, H Lipman, J A Elliott, M J Crain, P C Tien, A J Parkinson, M Davidson, R R Facklam, R F Breiman.   

Abstract

BACKGROUND: Children < 2 years old living in the Yukon-Kuskokwim Delta (YKD) region of Alaska have one of the highest pneumococcal bacteremia rates of in the world.
METHODS: To determine the prevalence of and risk factors for infection with intermediate or resistant Streptococcus pneumoniae in the YKD, we cultured nasopharyngeal secretions of healthy children < or = 5 years old, reviewed their hospital records and administered questionnaires to accompanying parents.
RESULTS: Of 185 children evaluated we obtained 95 pneumococcal isolates; drug susceptibility patterns and serotyping results were available for 92. Of these, 33 (36%) were intermediate or resistant to at least one drug class tested; 27 isolates were intermediate (minimum inhibitory concentration 0.1 to 1.0 mg/l) and none were resistant to penicillin. Compared with other isolates, capsular serotype 6B isolates were more likely to be intermediate or resistant to at least one drug (relative risk, 5.3; P < 0.001) and to more than one drug (relative risk, 17.0; P < 0.001). The majority of 6B isolates had identical pneumococcal surface protein A patterns. Carriage of intermediate or resistant pneumococcus was associated with age < 2 years (relative risk, 3.0; P < 0.001) but not with antibiotic use or other evaluated risk factors.
CONCLUSIONS: Young age but not antibiotic use was associated with carriage of intermediate or resistant S. pneumoniae in the YKD region of Alaska. Much of the intermediate or resistant pneumococcus in the YKD may have resulted from the proliferation of a single capsular serotype 6B clone.

Entities:  

Mesh:

Year:  1996        PMID: 8933546     DOI: 10.1097/00006454-199611000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation.

Authors:  Samir K Saha; Abdullah H Baqui; Gary L Darmstadt; M Ruhulamin; Mohammed Hanif; Shams El Arifeen; Mathuram Santosham; Kazunori Oishi; Tsuyoshi Nagatake; Robert E Black
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Nasopharyngeal carriage, antibiogram & serotype distribution of Streptococcus pneumoniae among healthy under five children.

Authors:  K L Ravi Kumar; Vandana Ashok; Feroze Ganaie; A C Ramesh
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

3.  Nasopharyngeal pneumococcal carriage in South Asian infants: Results of observational cohort studies in vaccinated and unvaccinated populations.

Authors:  Aditi Apte; Girish Dayma; Hakka Naziat; Linda Williams; Sonali Sanghavi; Jamal Uddin; Anand Kawade; Maksuda Islam; Sanchita Kar; You Li; Moe H Kyaw; Sanjay Juvekar; Harry Campbell; Harish Nair; Samir K Saha; Ashish Bavdekar
Journal:  J Glob Health       Date:  2021-09-04       Impact factor: 4.413

4.  Pneumococcal serotypes recovered from health children and their possible association with risk factor in istanbul, Turkey.

Authors:  Ferhat Cekmez; Ferhan Karademir; I Asya Tanju; Cihan Meral; Ozgur Pirgon; Mustafa Ozyurt; Ismail Gocmen
Journal:  Int J Biomed Sci       Date:  2009-06

5.  Nasopharyngeal Gram-Negative bacilli colonization in brazilian children attending day-care centers.

Authors:  Ana Beatriz Mori Lima; Lara Stefânia Netto de Oliveira Leão; Luciana Silva da Cruz Oliveira; Fabiana Cristina Pimenta
Journal:  Braz J Microbiol       Date:  2010-03-01       Impact factor: 2.476

6.  Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.

Authors:  Ifedayo M O Adetifa; Martin Antonio; Christy A N Okoromah; Chinelo Ebruke; Victor Inem; David Nsekpong; Abdoulie Bojang; Richard A Adegbola
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.